Promotion Agreement, Dated December 10, 2018
Aug 9 (Reuters) - Exagen Inc XGN.O :
* EXAGEN INC - ON AUGUST 5, 2021, THE COMPANY AND JANSSEN
BIOTECH
MUTUALLY AGREED TO TERMINATE THE CO-PROMOTION AGREEMENT, DATED
DECEMBER 10, 2018
* EXAGEN INC - ENTITLED TO RECEIVE AN AGGREGATE OF $0.6
MILLION IN
CONSIDERATION.
Further company coverage: XGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance